Urologix's CEO Discusses F3Q2012 Results - Earnings Call Transcript

Urologix, Inc. (ULGX)

F3Q2012 Results Earnings Call

April 26, 2012 5:00 PM ET

Executives

Stryker Warren, Jr. – Chief Executive Officer

Brian Smrdel – Chief Financial Officer

Greg Fluet – Executive Vice President and COO

Analysts

Jeff Adams – Private Investor

Deepak Chaulagai – Dougherty & Company

Larry Haimovitch – HMTC

Presentation

Operator

Good day, ladies and gentlemen. And welcome to the Urologix Incorporated Fiscal Year 2012 Third Quarter Conference Call. My name is Bill, and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of the conference. As a reminder, this conference is being recorded for replay purposes.

Certain information discussed during this conference call, including answers to your questions, may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Actual results may differ materially from those stated or implied in any forward-looking statements due to risks and uncertainties. A detailed discussion of risks and uncertainties maybe found in Urologix’s recent report on Form 10-K for the year ended June 30, 2011, and other documents filed with the Securities and Exchange Commission. Urologix disclaims any obligation to update any forward-looking statements made during the course of this call.

At this time, I will turn over the call to Mr. Stryker Warren, Jr., Chief Executive Officer. Please proceed, sir.

If you liked this article you might like

Urologix's CEO Discusses F4Q2012 Results - Earnings Call Transcript

Urologix's CEO Discusses F2Q2012 Results - Earnings Call Transcript

Urologix's CEO Presents At Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript

Urologix's CEO Presents At Lazard Capital Markets 8th Annual Healthcare Conference - Conference Call Transcript

Urologix's CEO Discusses F1Q2012 Results - Earnings Call Transcript

Urologix's CEO Discusses F1Q2012 Results - Earnings Call Transcript